* | The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. |
CUSIP No. U3762T121 | Page 2 of 7 Pages | ||||||||
(1) | Names of reporting persons Medtronic plc | ||||||||
(2) | Check the appropriate box if a member of a group (see instructions) (a) ¨ (b) ¨ | ||||||||
(3) | SEC use only | ||||||||
(4) | Citizenship or place of organization Ireland | ||||||||
Number of shares beneficially owned by each reporting person with | (5) | Sole voting power 0 | |||||||
(6) | Shared voting power 0 | ||||||||
(7) | Sole dispositive power 0 | ||||||||
(8) | Shared dispositive power 0 | ||||||||
(9) | Aggregate amount beneficially owned by each reporting person 0 | ||||||||
(10) | Check if the aggregate amount in Row (9) excludes certain shares (see instructions) ¨ | ||||||||
(11) | Percent of class represented by amount in Row (9) 0% | ||||||||
(12) | Type of reporting person (see instructions) OO |
CUSIP No. U3762T121 | Page 3 of 7 Pages | ||||||||
(1) | Names of reporting persons Medtronic, Inc. | ||||||||
(2) | Check the appropriate box if a member of a group (see instructions) (a) ¨ (b) ¨ | ||||||||
(3) | SEC use only | ||||||||
(4) | Citizenship or place of organization MN | ||||||||
Number of shares beneficially owned by each reporting person with | (5) | Sole voting power 0 | |||||||
(6) | Shared voting power 0 | ||||||||
(7) | Sole dispositive power 0 | ||||||||
(8) | Shared dispositive power 0 | ||||||||
(9) | Aggregate amount beneficially owned by each reporting person 0 | ||||||||
(10) | Check if the aggregate amount in Row (9) excludes certain shares (see instructions) ¨ | ||||||||
(11) | Percent of class represented by amount in Row (9) 0% | ||||||||
(12) | Type of reporting person (see instructions) CO |
Item 1(a) | Name of Issuer: |
Item 1(b) | Address of Issuer’s Principal Executive Offices: |
Item 2(a) | Name of Persons Filing: |
Item 2(b) | Address of Principal Business Office or, if None, Residence: |
Item 2(c) | Citizenship: |
Item 2(d) | Title of Class of Securities: |
Item 2(e) | CUSIP Number: |
Item 3 | If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a: | |
(a) | ¨ Broker or dealer registered under Section 15 of the Act. | |
(b) | ¨ Bank as defined in Section 3(a)(6) of the Act. | |
(c) | ¨ Insurance company as defined in Section 3(a)(19) of the Act. | |
(d) | ¨ Investment company registered under Section 8 of the Investment Company Act of 1940. | |
(e) | ¨ An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E). | |
(f) | ¨ An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F). | |
(g) | ¨ A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G). | |
(h) | ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act. | |
(i) | ¨ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act. | |
(j) | ¨ A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J); |
(k) | ¨ Group, in accordance with § 240.13d-1(b)(1)(ii)(K). |
Item 4 | Ownership |
Item 5 | Ownership of Five Percent or Less of a Class: |
Item 6 | Ownership of More than Five Percent on Behalf of Another Person: |
Item 7 | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person: |
Item 8 | Identification and Classification of Members of the Group: |
Item 9 | Notice of Dissolution of Group: |
Item 10 | Certifications: |
Exhibits | Joint Filing Agreement, dated February 16, 2016, between Medtronic plc and Medtronic, Inc. , incorporated by reference to the Exhibit to the Schedule 13G for the Issuer filed by Medtronic plc and Medtronic, Inc. on February 16, 2016. |
Date: | February 1, 2019 | Medtronic plc |
/s/ Karen L. Parkhill | ||
Karen L. Parkhill | ||
Executive Vice President and | ||
Chief Financial Officer | ||
Date: | February 1, 2019 | Medtronic, Inc. |
/s/ Philip J. Albert | ||
Philip J. Albert | ||
Vice President |